Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18603373rdf:typepubmed:Citationlld:pubmed
pubmed-article:18603373lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:18603373lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:18603373lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:18603373lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:18603373lifeskim:mentionsumls-concept:C1335671lld:lifeskim
pubmed-article:18603373pubmed:issue2lld:pubmed
pubmed-article:18603373pubmed:dateCreated2008-7-15lld:pubmed
pubmed-article:18603373pubmed:abstractTextChanges of cardiac M2-muscarinic receptor (M2-mAChR) gene expression was investigated in type-1 like diabetic rats induced by intravenous injection of streptozotocin (STZ) and type-2 like diabetic rats induced by fed with fructose-rich chow. Systolic blood pressure (SBP) in STZ-diabetic rats was significantly lower than that in age-matched non-diabetic rats, while the SBP in type-2 like diabetic rats was higher than in non-diabetic rats. Also, the mRNA or protein level of cardiac M2-mAChR in STZ-diabetic rats was markedly higher than non-diabetic rats, but it was not observed in type-2 like diabetic rats as compared to age-matched non-diabetic rats. Arecaidine propargyl ester (APE), the agonist of M2-mAChR, produced a marked reduction of heart rate in STZ-diabetic rats but made less influence on heart rate in fructose-fed rats or non-diabetic rats. The results suggest that cardiac M2-mAChR gene expression is raised in type-1 like diabetic rats but not in type-2 like diabetic rats, this difference mainly due to hyperglycemia, for the production of hypotension in diabetic disorders.lld:pubmed
pubmed-article:18603373pubmed:languageenglld:pubmed
pubmed-article:18603373pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18603373pubmed:citationSubsetIMlld:pubmed
pubmed-article:18603373pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18603373pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18603373pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18603373pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18603373pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18603373pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18603373pubmed:statusMEDLINElld:pubmed
pubmed-article:18603373pubmed:monthAuglld:pubmed
pubmed-article:18603373pubmed:issn0304-3940lld:pubmed
pubmed-article:18603373pubmed:authorpubmed-author:LiuI-MinIMlld:pubmed
pubmed-article:18603373pubmed:authorpubmed-author:ChengJuei-Tan...lld:pubmed
pubmed-article:18603373pubmed:authorpubmed-author:LeeLiang-Ming...lld:pubmed
pubmed-article:18603373pubmed:authorpubmed-author:ChangCheng...lld:pubmed
pubmed-article:18603373pubmed:authorpubmed-author:ChengKai-Chun...lld:pubmed
pubmed-article:18603373pubmed:authorpubmed-author:KouDai-HuangD...lld:pubmed
pubmed-article:18603373pubmed:issnTypePrintlld:pubmed
pubmed-article:18603373pubmed:day22lld:pubmed
pubmed-article:18603373pubmed:volume441lld:pubmed
pubmed-article:18603373pubmed:ownerNLMlld:pubmed
pubmed-article:18603373pubmed:authorsCompleteYlld:pubmed
pubmed-article:18603373pubmed:pagination201-4lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:meshHeadingpubmed-meshheading:18603373...lld:pubmed
pubmed-article:18603373pubmed:year2008lld:pubmed
pubmed-article:18603373pubmed:articleTitleIncrease of cardiac M2-muscarinic receptor gene expression in type-1 but not in type-2 diabetic rats.lld:pubmed
pubmed-article:18603373pubmed:affiliationDepartment of Urology, College of Medicine and Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan, ROC.lld:pubmed
pubmed-article:18603373pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18603373pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18603373pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18603373lld:pubmed